Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- e-Trial Proposes Multinational Trials Including China
August 7, 2006
- GENERIC NEWS IN BRIEF
August 7, 2006
- MEDICAL DEVICE NEWS IN BRIEF
August 7, 2006
- Approval of 32 Products Released
August 7, 2006
- All-case Studies Increasingly a Condition for Approval: OPIR
August 7, 2006
- Council Recommends Early Approval of 4 Drugs
August 7, 2006
- Chuikyo Listens to FPMAJ, PhRMA, EFPIA on Drug Pricing
August 7, 2006
- JMA Opposed to More Frequent NHI Price Revision
August 7, 2006
- SELF-MEDICATION NEWS IN BRIEF
August 7, 2006
- REGULATORY NEWS IN BRIEF
August 7, 2006
- Santen Aims for Global Business Development in FY2006-2010 Management Plan
August 7, 2006
- DSP, BMKK Enter Agreements for Hypertension, Cancer Treatments
August 7, 2006
- Meiji Seika Licenses Non-steroidal Compounds to US Company
August 7, 2006
- 24 Products Currently in Vaccine Pipeline: GSK
August 7, 2006
- Eisai, Solvay Announce License Agreement for SA-001
August 7, 2006
- Wyeth Focuses on Developing 2nd-Generation Pneumococcal Vaccine
August 7, 2006
- New Laws Shorten "Drug Lag" in China: Mr Kosaku of CMIC
August 7, 2006
- Drug Development Beyond Borders - Today's Global Cooperative Clinical Trials -
August 7, 2006
- REGULATORY NEWS IN BRIEF
July 31, 2006
- MEDICAL DEVICE NEWS IN BRIEF
July 31, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…